61 results match your criteria: "Omagari Kosei Medical Center[Affiliation]"

Article Synopsis
  • The study investigates the effectiveness of durvalumab, an immunotherapy drug, after chemoradiotherapy in patients with unresectable locally advanced non-small-cell lung cancer (LA-NSCLC), particularly those with poorer performance status or older age.
  • In a phase II trial with 86 participants, 61 received durvalumab after low-dose carboplatin and radiotherapy, showing a 12-month progression-free survival (PFS) rate of 51%, exceeding the expected 35%.
  • The treatment was deemed effective, with a median overall survival of 28.1 months, but pneumonitis was noted as the most common severe side effect.*
View Article and Find Full Text PDF
Article Synopsis
  • Researchers created and validated a risk model for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) patients treated with abiraterone acetate (ABI) to better predict patient outcomes.
  • The study involved 233 patients from three academic centers and validated the model on a separate group of 282 patients, analyzing factors that influence progression-free survival (PFS2) and overall survival (OS).
  • Key findings showed that the model effectively categorized patients into risk groups, with poor-risk patients having significantly lower median PFS2 and OS compared to favorable and intermediate groups, aiding in treatment planning.
View Article and Find Full Text PDF
Article Synopsis
  • A nationwide study in Japan investigated the cancer risk associated with different lengths of Barrett's esophagus (BE) among 33,478 subjects who underwent endoscopy between 2013 and 2017, with follow-ups until 2022.
  • The findings showed that the incidence of esophageal adenocarcinoma increased with the length of BE, with higher risks for those with BE lengths of 1-3 cm and ≥3 cm.
  • The study highlights the importance of considering the length of BE in managing patients, as longer BE is correlated with a greater cancer risk.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the risks and survival outcomes for non-small cell lung cancer (NSCLC) patients with pre-existing autoimmune disorders (AIDs) undergoing immune checkpoint blockade (ICB) therapy.
  • Conducted across 20 centers in Japan, it analyzed data from 229 patients, revealing that 25.4% experienced AID flare-ups while receiving ICB, particularly those diagnosed with NSCLC within a year of their AID diagnosis.
  • The results suggest that ICB therapy not only extends survival but also emphasizes its potential benefit for NSCLC patients with AIDs, despite some associated immune-related adverse effects.
View Article and Find Full Text PDF

Surgery for benign prostatic hyperplasia (BPH) has greatly advanced with the development of laser technology ; and holmium laser enucleation of the prostate (HoLEP), which can be performed safely and with minimal invasiveness regardless of prostate size. Incidental prostate carcinoma (iPCa) following HoLEP occurs at a certain rate. Predictors, include age, biopsy, history, preoperative prostate specific antigen, and prostate volume.

View Article and Find Full Text PDF
Article Synopsis
  • EGFR-TKIs like afatinib and osimertinib are effective for treating non-small cell lung cancer with EGFR mutations, but high PD-L1 levels may lead to poorer responses.
  • A study analyzed 177 patients with PD-L1-positive EGFR-mutant NSCLC to compare the effectiveness of afatinib versus osimertinib.
  • The findings indicated no significant difference in progression risk or overall survival between the two treatments, suggesting similar effectiveness for patients with this specific cancer profile.
View Article and Find Full Text PDF

A patient who received a loop sigmoid colostomy was diagnosed with ulcerative colitis (pancolitis type) and treated with infliximab. Thereafter, he relapsed with intestinal inflammation only on the rectal side of the loop sigmoid colostomy and not on the oral side. Autologous fecal microbiota transplantation from the proximal intestine to the distal intestine was performed to treat the inflammation but was ineffective.

View Article and Find Full Text PDF

It has been postulated that being breastfed in infancy affects not only health status in childhood but also disease risk in adulthood. To investigate the association of being breastfed with the risks of adult colorectal cancer and benign tumor, we conducted a case-control study including 1190 colorectal cancer and 1585 benign tumor cases and 5301 controls, admitted to a single hospital in Miyagi Prefecture, Japan, between 1997 and 2013. History of having been breastfed was assessed using a self-administered questionnaire, and odds ratios (ORs) were estimated using unconditional logistic regression.

View Article and Find Full Text PDF

The long-term impact of the coronavirus disease 2019 (COVID-19) pandemic on the disruption of gastrointestinal cancer diagnoses remains unclear. This study investigated the actual impact on esophagogastric cancer (EGC) and colorectal cancer (CRC) diagnoses up to the third year of the pandemic in Akita Prefecture, Japan, using population-based registry data. We collected data on the annual number of EGC and CRC diagnoses using a database from the collaborative Akita Prefecture hospital-based registration.

View Article and Find Full Text PDF

Background: Since gastric cancers (GCs) detected after () eradication present with different morphological characteristics from conventional -positive GCs, delayed detection of early-stage GCs may be observed. This study aimed to investigate the clinical impact of eradication on diagnosing GC during screening endoscopy.

Methods: Eleven health checkup institutions in Japan participated in the present study.

View Article and Find Full Text PDF

Background: The factors that predict the clinical response to ramucirumab plus docetaxel (RD) after first-line chemoimmunotherapy are unresolved. We explored whether the therapeutic efficacy of prior chemoimmunotherapy could predict the outcome of RD as sequential therapy in patients with advanced non-small cell lung cancer (NSCLC).

Methods: Our study comprised 288 patients with advanced NSCLC who received RD as the second-line treatment after first-line chemoimmunotherapy at 62 Japanese institutions.

View Article and Find Full Text PDF

Osimertinib is a standard treatment for patients with EGFR-mutated non-small cell lung carcinoma (NSCLC). We evaluated the relationship between plasma osimertinib concentrations and treatment outcome in patients with NSCLC for this cohort study. The plasma levels of osimertinib and its metabolite AZ5104 were measured a week after the start of treatment (P1).

View Article and Find Full Text PDF
Article Synopsis
  • Recent studies highlight gluteus medius tendinous injuries as key contributors to greater trochanteric pain syndrome (GTPS), with surgical techniques like tendon repair showing promising outcomes.
  • A case study at our department involved 22 patients who underwent arthroscopic surgery for GTPS, confirming bursitis in all affected joints and leading to significant pain relief.
  • Post-surgery, pain levels significantly decreased on the Numerical Rating Scale, while hip function improved dramatically according to the modified Harris Hip Score, indicating that greater trochanteric bursitis and gluteus medius injuries are prevalent in lateral hip pain cases.
View Article and Find Full Text PDF
Article Synopsis
  • * Data from 263 patients were analyzed, showing combined therapy resulted in a lower risk of cancer progression (hazard ratio of 0.47) compared to first- and second-generation EGFR-TKIs.
  • * The results suggest that combined therapy may offer a promising treatment option for NSCLC patients, as it shows improved progression-free survival compared to EGFR-TKI alone.
View Article and Find Full Text PDF

Background: The daytime tiredness experienced by the vast majority of allergic rhinitis (AR) sufferers is directly related to the fact that they experience disrupted sleep at night. This study compared the effects of recently marketed second-generation H1 antihistamines (SGAs) on nighttime sleep and daytime sleepiness in patients with AR, with patients grouped into those taking non-brain-penetrating antihistamines (NBP group) and those taking brain-penetrating antihistamines (BP group).

Methods: Patients with AR completed self-administered questionnaire-based surveys to determine Pittsburgh Sleep Quality Index (PSQI) before and after taking SGAs.

View Article and Find Full Text PDF

Objectives: Postoperative pulmonary complications (PPCs) provoke an extended hospital stay and increased postoperative mortality. Although several factors can cause PPCs, smoking is the only factor that can be adjusted within a short period of time preoperatively. However, the optimal period of smoking cessation to reduce the risk of PPCs remains unclear.

View Article and Find Full Text PDF

The purpose of this study was to propose a novel classification of varus thrust based on gait analysis with inertial motion sensor units (IMUs) in patients with medial knee osteoarthritis (MKOA). We investigated thigh and shank acceleration using a nine-axis IMU in 69 knees with MKOA and 24 (control) knees. We classified varus thrust into four phenotypes according to the relative medial-lateral acceleration vector patterns of the thigh and shank segments: pattern A (thigh medial, shank medial), pattern B (medial, lateral), pattern C (lateral, medial), and pattern D (lateral, lateral).

View Article and Find Full Text PDF

We recently reported the decrease in the number of gastrointestinal (GI) cancer diagnoses in 2020 due to disturbance of the healthcare system by the coronavirus disease 2019 (COVID-19) pandemic, using a hospital-based cancer registration system in Akita prefecture, Japan. In this study, we extended the research by showing the latest data (2021) on the number of cancers and examinations. Information on the occurrence and stage of esophageal, gastric, and colorectal cancers was collected from the same database.

View Article and Find Full Text PDF

Background: The guidelines recommend additional gastrectomy after noncurative endoscopic resection for early gastric cancers (EGCs). However, no additional treatment might be acceptable in some patients aged ≥ 85 years. We aimed to identify this patient group using the data in a highly aged area.

View Article and Find Full Text PDF

Purpose: We evaluated plasma cell-free DNA (cfDNA) and tissue-based sequencing concordance for comprehensive oncogenic driver detection in non-small cell lung cancer (NSCLC) using a large-scale prospective screening cohort (LC-SCRUM-Liquid).

Experimental Design: Blood samples were prospectively collected within 4 weeks of corresponding tumor tissue sampling from patients with advanced NSCLC to investigate plasma cfDNA sequencing concordance for alterations in 8 oncogenes (EGFR, KRAS, BRAF, HER2, MET, ALK, RET, and ROS1) compared with tissue-based next-generation targeted sequencing.

Results: Paired blood and tissue samples were obtained in 1,062/1,112 enrolled patients with NSCLC.

View Article and Find Full Text PDF

Introduction: Malignant tumors are the major cause of death in hemodialysis patients. Management of these patients remains challenging as there is no evidence that chemotherapy is beneficial, and a lack of information about actual clinical practice.

Methods: This multicenter retrospective study included hemodialysis patients who were diagnosed with lung cancer from January 2002 to June 2018.

View Article and Find Full Text PDF

We report a case of atypical femoral fracture achieving early fracture union with combination therapy comprising contralateral nail and immediate teriparatide injection. Fracture union of atypical fractures is often delayed due to bowing deformity and bone metabolic disorders. Combination treatment that takes both problems into consideration represents a useful treatment option for atypical femoral fracture.

View Article and Find Full Text PDF

Purpose: We assessed clinical outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with two upfront therapies.

Methods: The medical records of 301 patients with mCSPC treated with androgen deprivation therapy plus upfront abiraterone acetate (ABI) or docetaxel (DOC) between 2014 and 2021 were retrospectively reviewed. Propensity score matching (PSM) was performed to compare survival outcomes.

View Article and Find Full Text PDF

Background: There are two distinct etiologies of esophago-gastric junctional adenocarcinomas (EGJACs): one associated with extensive gastric mucosal atrophy (GA), resembling non-cardiac gastric cancers; and the other related to gastro-esophageal reflux disease, resembling esophageal adenocarcinoma. In this study, we investigated the associations between the visceral fat area (VFA) and EGJACs separately in the two subtypes of EGJACs, depending on the extent of background GA.

Methods: Sixty-four consecutive patients with EGJACs (Siewert type 2) were enrolled from a population-based database in Akita Prefecture, Japan, between 2014 and 2019.

View Article and Find Full Text PDF